PGNX

Progenics Pharmaceuticals Inc. News Headlines

$4.695
*  
0.105
2.19%
Get PGNX Alerts
*Delayed - data as of Oct. 21, 2014 14:45 ET  -  Find a broker to begin trading PGNX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PGNX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog
10/7/2014 5:05:00 PM - Zacks.com


ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod
10/7/2014 4:37:00 AM - RTT News


Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog
10/2/2014 5:20:00 PM - Zacks.com


Progenics: Inexpensive Way To Win Big 3 Potential Ways
10/2/2014 1:48:00 PM - Seeking Alpha


Sector Update: Health Care Shares Flat in Pre-Market Trade
9/30/2014 8:26:01 AM - MT Newswires


Sector Update: Health Care
9/30/2014 8:25:27 AM - MT Newswires


SLXP Gets FDA Nod, Catalyst Makes Right Moves, TKAI On Watch, AMAG Opens Wallet
9/30/2014 1:08:00 AM - RTT News


SLXP Gets FDA Nod, Catalyst Makes Right Moves, TKAI On Watch, AMAG Opens Wallet
9/30/2014 1:08:00 AM - RTT News


Salix Says FDA OKs Expanded Use Of Relistor Subcutaneous Injection
9/29/2014 6:54:00 PM - RTT News


Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog
9/23/2014 6:10:00 PM - Zacks.com


Sector Update: Health Care Stocks Dropping; Early Progenic Gains Slip Away Despite Data Supporting More Testing of Cancer Drug
9/22/2014 1:48:43 PM - MT Newswires


Sector Update: Health Care
9/22/2014 1:38:17 PM - MT Newswires


AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog
9/17/2014 4:45:00 PM - Zacks.com


2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha


Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog
8/12/2014 9:20:00 AM - Zacks.com


Salix Pharma Provides Update On RELISTOR SNDA - Quick Facts
8/11/2014 7:15:00 AM - RTT News


Progenics Pharma Q2 Loss Narrows
8/8/2014 12:44:00 PM - RTT News


Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog
8/7/2014 3:50:00 PM - Zacks.com


An Inefficient Stock Market Will Catch Up To Progenics
7/21/2014 4:26:00 PM - Seeking Alpha


Funds Are Buying These 5 Rallying Stocks Under $5
7/18/2014 10:00:00 AM - Seeking Alpha


Progenics-Salix Up on Encouraging Relistor News - Analyst Blog
7/15/2014 4:45:00 PM - Zacks.com


Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape
7/15/2014 8:44:00 AM - Zacks.com


Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to Mylan
7/14/2014 8:47:17 AM - MT Newswires


Sector Update: Health Care
7/14/2014 8:45:47 AM - MT Newswires


Pre-Market Most Active for Jul 14, 2014 : C, URS, AV, BAC, ABBV, MYL, PGNX, AAPL, GTAT, ALU, EXEL, QQQ
7/14/2014 8:39:54 AM - NASDAQ.com News